In 2025, IPC advanced the priorities outlined in our strategic plan, strengthening research collaboration, expanding regional education, and progressing focused clinical initiatives that address real-world gaps in psoriasis care. This encompassed ongoing efforts in disease severity reclassification, defining topical failure, examining cardiometabolic impacts on psoriasis, addressing complex clinical scenarios, commencing development of a comprehensive textbook on psoriasis, and delivering continued regional education via our Masterclasses.
Throughout the year, our Board Members, Councilors, and Jr. Councilors led scientific discussions, educational programming, and collaborative initiatives that reflect IPC’s role as a global network of physician experts. From international symposia to clinical guidance efforts, these contributions continue to shape how psoriasis care evolves across regions.
We are grateful to the many individuals and partners who volunteer their time, expertise, and leadership to IPC’s work. Their contributions are reflected throughout the progress summarized in this report.
We invite you to view the Annual Report below to learn more about IPC’s work in 2025.
Thank you for your continued engagement and partnership
Bruce Strober, MD, PhD
President
Christy Langan
Chief Executive Officer
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
